Posted October 15, 2018 12:30pm EDT By Alex HernsteinThe disease that afflicts many Lyme patients is caused by a parasite called Borrelia burgdorferi.
Borrelia is a bacteria that lives on the skin of many different animals, including humans.
Many people have a mild to moderate case of the illness, and the symptoms often begin after the infection has progressed.
People with the disease typically have a fever, muscle aches, cough, and pain that worsen over time.
Borglias cause the body to produce antibodies against the organism, which helps fight off the infection.
The antibodies help keep the body healthy.
The antibodies also help the body fight off other parasites, which are the cause of the disease in many people.
Bors disease is typically treated with antibiotics, antivirals, and other medicines.
People who live in areas where Lyme is common can have a higher risk of developing the disease, as the infection can cause inflammation of the joints and other areas.
The symptoms of Lyme often fade after treatment, and patients may have some or all of the symptoms return after a few weeks.
But with the number of cases rising, many doctors are beginning to question the importance of the immune system as a whole.
A recent study published in the journal PLOS Medicine suggests that certain types of immunosuppressive drugs could be effective at preventing Lyme disease from recurring in people who are sicker than usual.
The researchers studied a group of people with a higher prevalence of Lyme.
They found that people who took a combination of drugs called interferon beta-1a, interferons, and metronidazole had a lower risk of recurrent infection.
The researchers also looked at whether the drugs affected the immune response.
They found that the drugs slowed the rate at which the immune cells began to attack bacteria, which was related to a lower rate of Lyme in people taking them.
Interferon and metonidazoles are drugs that target the immune systems immune cells, which normally attack the bacteria that cause Lyme disease.
They also inhibit the immune reaction that is responsible for the disease.
People taking these drugs had lower levels of the bacteria-killing enzyme IL-10 in their blood, which suggests that they were less susceptible to Lyme.
A lower level of IL-8, which is the same molecule as IL-1, suggests that the people taking these medications were less sensitive to the infection than the people who didn’t take the drugs.
The drugs were found to help slow the rate of the infection and prevent recurrences in those taking them, the researchers said.
The study was conducted by researchers at the University of Pennsylvania’s Perelman School of Medicine, as well as at the Vanderbilt University Medical Center and Vanderbilt University.
More information about Lyme disease is available at: www.plosmedicine.org/articles/PMC2747861.